Impact of neuroleptic medications on continuous performance test measures in schizophrenia
Gespeichert in:
| Veröffentlicht in: | Biological psychiatry (1969) 1996-05, Vol.39 (10), p.902-905 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 905 |
|---|---|
| container_issue | 10 |
| container_start_page | 902 |
| container_title | Biological psychiatry (1969) |
| container_volume | 39 |
| creator | Epstein, Jane I. Keefe, Richard S.E. Roitman, Sonia Lees Harvey, Philip D. Mohs, Richard C. |
| description | |
| doi_str_mv | 10.1016/0006-3223(95)00588-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78441262</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0006322395005889</els_id><sourcerecordid>78441262</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-203cb6c371b07a4b4c5ad9878da2c1b3b04d63454d4d5f2b816897cf4d8fac583</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMo6_rxDxRyEj1U89U2vQiy-LEgeNGLl5BOUoxsk5q0gv56s-7i0dMwvO-8M_MgdELJJSW0uiKEVAVnjJ835QUhpZRFs4PmVNa8YIKwXTT_s-yjg5Tec1szRmdoJmVFaCPm6HXZDxpGHDrs7RTDyg6jA9xb40CPLviEg8cQ_Oj8FKaEBxu7EHvtweLRpjFbdZqiTdh5nODNfYfhLVrv9BHa6_Qq2eNtPUQvd7fPi4fi8el-ubh5LICX9VgwwqGtgNe0JbUWrYBSm0bW0mgGtOUtEabiohRGmLJjraSVbGrohJGdhlLyQ3S2yR1i-JjySap3Cexqpb3NF6taCkFZxbJRbIwQQ0rRdmqIrtfxS1Gi1kjVmpda81JNqX6RqiaPnW7zpzZz-RvaMsz69Ua3-clPZ6NK4GzmY1y0MCoT3P8LfgDUNocW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78441262</pqid></control><display><type>article</type><title>Impact of neuroleptic medications on continuous performance test measures in schizophrenia</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Epstein, Jane I. ; Keefe, Richard S.E. ; Roitman, Sonia Lees ; Harvey, Philip D. ; Mohs, Richard C.</creator><creatorcontrib>Epstein, Jane I. ; Keefe, Richard S.E. ; Roitman, Sonia Lees ; Harvey, Philip D. ; Mohs, Richard C.</creatorcontrib><identifier>ISSN: 0006-3223</identifier><identifier>EISSN: 1873-2402</identifier><identifier>DOI: 10.1016/0006-3223(95)00588-9</identifier><identifier>PMID: 8860194</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Antipsychotic Agents - pharmacology ; Antipsychotic Agents - therapeutic use ; Attention ; Attention - drug effects ; continuous performance test ; Female ; Homovanillic Acid - blood ; Homovanillic Acid - metabolism ; Humans ; Male ; medication ; Middle Aged ; neuroleptic ; schizophrenia ; Schizophrenia - drug therapy</subject><ispartof>Biological psychiatry (1969), 1996-05, Vol.39 (10), p.902-905</ispartof><rights>1996 Society of Biological Psychiatry</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-203cb6c371b07a4b4c5ad9878da2c1b3b04d63454d4d5f2b816897cf4d8fac583</citedby><cites>FETCH-LOGICAL-c357t-203cb6c371b07a4b4c5ad9878da2c1b3b04d63454d4d5f2b816897cf4d8fac583</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0006-3223(95)00588-9$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8860194$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Epstein, Jane I.</creatorcontrib><creatorcontrib>Keefe, Richard S.E.</creatorcontrib><creatorcontrib>Roitman, Sonia Lees</creatorcontrib><creatorcontrib>Harvey, Philip D.</creatorcontrib><creatorcontrib>Mohs, Richard C.</creatorcontrib><title>Impact of neuroleptic medications on continuous performance test measures in schizophrenia</title><title>Biological psychiatry (1969)</title><addtitle>Biol Psychiatry</addtitle><subject>Adult</subject><subject>Antipsychotic Agents - pharmacology</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Attention</subject><subject>Attention - drug effects</subject><subject>continuous performance test</subject><subject>Female</subject><subject>Homovanillic Acid - blood</subject><subject>Homovanillic Acid - metabolism</subject><subject>Humans</subject><subject>Male</subject><subject>medication</subject><subject>Middle Aged</subject><subject>neuroleptic</subject><subject>schizophrenia</subject><subject>Schizophrenia - drug therapy</subject><issn>0006-3223</issn><issn>1873-2402</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMo6_rxDxRyEj1U89U2vQiy-LEgeNGLl5BOUoxsk5q0gv56s-7i0dMwvO-8M_MgdELJJSW0uiKEVAVnjJ835QUhpZRFs4PmVNa8YIKwXTT_s-yjg5Tec1szRmdoJmVFaCPm6HXZDxpGHDrs7RTDyg6jA9xb40CPLviEg8cQ_Oj8FKaEBxu7EHvtweLRpjFbdZqiTdh5nODNfYfhLVrv9BHa6_Qq2eNtPUQvd7fPi4fi8el-ubh5LICX9VgwwqGtgNe0JbUWrYBSm0bW0mgGtOUtEabiohRGmLJjraSVbGrohJGdhlLyQ3S2yR1i-JjySap3Cexqpb3NF6taCkFZxbJRbIwQQ0rRdmqIrtfxS1Gi1kjVmpda81JNqX6RqiaPnW7zpzZz-RvaMsz69Ua3-clPZ6NK4GzmY1y0MCoT3P8LfgDUNocW</recordid><startdate>19960515</startdate><enddate>19960515</enddate><creator>Epstein, Jane I.</creator><creator>Keefe, Richard S.E.</creator><creator>Roitman, Sonia Lees</creator><creator>Harvey, Philip D.</creator><creator>Mohs, Richard C.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960515</creationdate><title>Impact of neuroleptic medications on continuous performance test measures in schizophrenia</title><author>Epstein, Jane I. ; Keefe, Richard S.E. ; Roitman, Sonia Lees ; Harvey, Philip D. ; Mohs, Richard C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-203cb6c371b07a4b4c5ad9878da2c1b3b04d63454d4d5f2b816897cf4d8fac583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adult</topic><topic>Antipsychotic Agents - pharmacology</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Attention</topic><topic>Attention - drug effects</topic><topic>continuous performance test</topic><topic>Female</topic><topic>Homovanillic Acid - blood</topic><topic>Homovanillic Acid - metabolism</topic><topic>Humans</topic><topic>Male</topic><topic>medication</topic><topic>Middle Aged</topic><topic>neuroleptic</topic><topic>schizophrenia</topic><topic>Schizophrenia - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Epstein, Jane I.</creatorcontrib><creatorcontrib>Keefe, Richard S.E.</creatorcontrib><creatorcontrib>Roitman, Sonia Lees</creatorcontrib><creatorcontrib>Harvey, Philip D.</creatorcontrib><creatorcontrib>Mohs, Richard C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biological psychiatry (1969)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Epstein, Jane I.</au><au>Keefe, Richard S.E.</au><au>Roitman, Sonia Lees</au><au>Harvey, Philip D.</au><au>Mohs, Richard C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of neuroleptic medications on continuous performance test measures in schizophrenia</atitle><jtitle>Biological psychiatry (1969)</jtitle><addtitle>Biol Psychiatry</addtitle><date>1996-05-15</date><risdate>1996</risdate><volume>39</volume><issue>10</issue><spage>902</spage><epage>905</epage><pages>902-905</pages><issn>0006-3223</issn><eissn>1873-2402</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>8860194</pmid><doi>10.1016/0006-3223(95)00588-9</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0006-3223 |
| ispartof | Biological psychiatry (1969), 1996-05, Vol.39 (10), p.902-905 |
| issn | 0006-3223 1873-2402 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_78441262 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Adult Antipsychotic Agents - pharmacology Antipsychotic Agents - therapeutic use Attention Attention - drug effects continuous performance test Female Homovanillic Acid - blood Homovanillic Acid - metabolism Humans Male medication Middle Aged neuroleptic schizophrenia Schizophrenia - drug therapy |
| title | Impact of neuroleptic medications on continuous performance test measures in schizophrenia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A48%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20neuroleptic%20medications%20on%20continuous%20performance%20test%20measures%20in%20schizophrenia&rft.jtitle=Biological%20psychiatry%20(1969)&rft.au=Epstein,%20Jane%20I.&rft.date=1996-05-15&rft.volume=39&rft.issue=10&rft.spage=902&rft.epage=905&rft.pages=902-905&rft.issn=0006-3223&rft.eissn=1873-2402&rft_id=info:doi/10.1016/0006-3223(95)00588-9&rft_dat=%3Cproquest_cross%3E78441262%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78441262&rft_id=info:pmid/8860194&rft_els_id=0006322395005889&rfr_iscdi=true |